Treatment News : Proof of Principle for a New HIV Microbicide in Study Among Primates

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » December 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


December 14, 2012

Proof of Principle for a New HIV Microbicide in Study Among Primates

New research has achieved a proof of principle that an investigatory microbicide gel is highly effective at preventing vaginal transmission of HIV, ScienceDaily Reports. Scientists from the European Combined Highly Active Anti-Retroviral Microbicides (CHAARM) Consortium published their study of non-human primates in the Open Access journal of PLOS Pathogens.

The researchers engineered peptides known as “miniCD4s” that mimic the CD4 co-receptor HIV binds to before entering the immune cell. The peptides succeed in preventing transmission by effectively becoming a decoy the virus binds to instead of to the body’s cells. After studying the miniCD4s’ efficacy in a petri dish and in tissue models that mimic mucous membranes, researchers formulated a 0.3 percent microbicide gel and inserted it into the vaginas of six cynomolgus macaques monkeys an hour before then inserting a high dose of HIV. While that dose of the virus would ordinarily infect all the monkeys, in this case it only infected one.

To read the ScienceDaily article, click here.

To read the study, click here.

Search: HIV, microbicide, primate, vaginal transmission, ScienceDaily, European Combined Highly Active Anti-Retroviral Microbicides Consortium, CHAARM, miniCD4s, peptides, gel, cynomolgus macaques monkey, prevention.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.